Females more prone to brain damage from alcohol abuse

Alcoholism has traditionally been considered a male disease because there are many more alcoholic males than females.

But a new study by researchers at Oregon Health & Science University and the Portland Veterans Affairs Medical Center suggests that women are more prone to brain damage from alcohol abuse than men.

The study led by Kristine Wiren, Ph.D., associate professor of behavioral neuroscience and medicine, OHSU School of Medicine, and research biologist, PVAMC Research Service, found that female mice are more susceptible to neurotoxic effects of alcohol withdrawal, including significantly increased brain cell death, than male mice. It also found the gender difference exists whether the animals are prone to severe withdrawal due to a genetic predisposition, or resistant to it.

Wiren said she was surprised by the results.

"We designed the experiment to be able to identify gene expression differences between lines of mice that are genetically selected for severe alcohol withdrawal compared with mice that are resistant to alcohol withdrawal," Wiren said. "I thought there would be a difference between the genders, but I didn't think it would be the most important thing."

She added, "The withdrawal severity phenotypes do show some differences, but they're subtle."

The study appears in the online edition of the journal Neuropsychopharmacology.

Wiren and Joel Hashimoto, research associate of behavioral neuroscience at OHSU and the PVAMC Research Service, examined four groups of selectively bred mice: two female groups, including one prone to severe withdrawal and one resistant to severe withdrawal, and two similar male groups. Four control groups also were used.

Using DNA microarray or "gene chip" analysis, a laboratory process involving advanced robotics that allows large numbers of genes and their complex interactions to be observed, Wiren and Hashimoto examined 5,000 genes from the prefrontal cortex, the area of the brain implicated in complex planning, personality expression and social behavior, and is involved in withdrawal-related brain circuitry. They then identified a total of 295 alcohol-regulated genes for each mouse group.

"We're interested in that part of the brain because it's important in inhibitory control. Alcoholics are unable to display good inhibitory control," Wiren said.

After identifying the alcohol-regulated gene pathways, Wiren and Hashimoto were able to home in on the extent of cell death. Ten days after alcohol withdrawal, they examined cells in the lateral parietal cortex area, which is part of the network of brain regions, in addition to the prefrontal cortex, involved in inhibitory control, and identified live and dead cells with tissue stains.

"At this one time point, which is the peak for cell death, we clearly see females are showing enhanced brain damage compared to the males. So, if you're female, the cells are dying; if you're a male, the cells are not," Wiren said. "We don't know the behavioral consequences of that, though."

What's more, Wiren and Hashimoto discovered, male brains respond to alcohol withdrawal much differently, in a potentially reparative manner.

"What we found in males is that almost 50 percent of the (alcohol-regulated) genes are involved in the pathway for cleaning things up," Wiren said. The genes respond with "removal of damaged proteins. The females have all this apoptosis (cell death) going on, and the males instead may have repair going on."

Such brain damage may underlie debilitating cognitive dysfunction and motor deficits observed in some alcoholics, according to the study. In addition, disruption of inhibitory functions in the prefrontal cortex may contribute to excessive drinking and the self-sustaining nature of alcoholism.

"The results suggest that females are more vulnerable to neurotoxic consequences of alcohol withdrawal," Wiren noted. "Everyone should be concerned about chronic alcohol consumption and severe intoxication, but females may be more vulnerable." This data is "consistent with some controversial human studies that suggest that females do develop more brain damage than male alcoholics."

Future studies, including one funded by the VA, will examine the role that hormones play in response to alcohol withdrawal, include the possibility that the male hormone androgen exacerbates cell death in males.

"What we're looking at now is the involvement of testosterone in mediating the cell death in females," Wiren said. "Not just in chronic conditions, but in acute (alcohol consumption) situations, testosterone levels drop in males. In females, they may rise."

Wiren also wants to look at a longer withdrawal time course. "Maybe males show damage at a different time point," she said. "Or it might have happened earlier and they're showing repair."

Source: Oregon Health & Science University

Related stories:

Survey: 'Tanorexia' common among university students
A new study conducted at a large university finds more than 25 percent of those surveyed reported symptoms of tanning dependence, including symptoms similar to alcohol and drug-addicted individuals. Suggestively, the study also found those with a tanning dependence tend to be more likely to be thin and smoke cigarettes than others. The study by researchers at Fox Chase Cancer Center is published in the September/October issue of the American Journal of Health Behavior.
Research reveals why some smokers become addicted with their first cigarette
New research from The University of Western Ontario reveals how the brain processes the 'rewarding' and addictive properties of nicotine, providing a better understanding of why some people seemingly become hooked with their first smoke. The research, led by Steven Laviolette of the Department of Anatomy and Cell Biology at the Schulich School of Medicine & Dentistry could lead to new therapies to prevent nicotine dependence and to treat nicotine withdrawal when smokers try to quit. The paper is published in the August 6th Journal of Neuroscience.
Prescribed Meds is Still Best Path to Alcoholism Recovery
Some drugs can reduce withdrawal symptoms and the urge to drink alcohol, but they will not work if patients stop taking them. A study by Columbia researchers found that while behavioral treatments can help people remain on their medication, different combinations have different effects on different people.
Scientists find seizure drug reverses cellular effects
In the new research, published in the May 28, 2008 edition of The Journal of Neuroscience, the scientists found that gabapentin normalizes the action of certain brain cells altered by chronic alcohol abuse in an area of the brain known as the central amygdala, which plays an important role in fear- and stress-related behaviors, as well as in regulating alcohol drinking. In the study, alcohol-dependent rodents receiving gabapentin drank less alcohol.
New study reveals brain cell mechanism of alcohol dependence
A study released today reveals a cellular mechanism involved in alcohol dependence. The study, in the May 28 issue of The Journal of Neuroscience, shows that gabapentin, a drug used to treat chronic pain and epilepsy, reduces alcohol intake in alcohol-dependent rats by normalizing chemical communication between neurons, which is altered by chronic alcohol abuse.
Research sheds new light on heroin addiction
Researchers from the Howard Florey Institute in Melbourne have identified a factor that may contribute towards the development of heroin addiction by manipulating the adenosine A2A receptor, which plays a major role in the brain’s ‘reward pathway’.
Brain DNA 'remodeled' in alcoholism
Reshaping of the DNA scaffolding that supports and controls the expression of genes in the brain may play a major role in the alcohol withdrawal symptoms, particularly anxiety, that make it so difficult for alcoholics to stop using alcohol.
Brain chemistry ties anxiety and alcoholism
Doctors may one day be able to control alcohol addiction by manipulating the molecular events in the brain that underlie anxiety associated with alcohol withdrawal, researchers at the University of Illinois at Chicago College of Medicine and the Jesse Brown VA Medical Center report in the March 5 issue of the Journal of Neuroscience.

News discussion:

Medicine & Health news